232 related articles for article (PubMed ID: 24631529)
1. Gα12gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation.
Jung HS; Seo YR; Yang YM; Koo JH; An J; Lee SJ; Kim KM; Kim SG
Cell Signal; 2014 Jul; 26(7):1456-65. PubMed ID: 24631529
[TBL] [Abstract][Full Text] [Related]
2. Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction.
Yang YM; Lee CG; Koo JH; Kim TH; Lee JM; An J; Kim KM; Kim SG
Oncotarget; 2015 Aug; 6(22):19055-69. PubMed ID: 25965999
[TBL] [Abstract][Full Text] [Related]
3. Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.
Yang YM; Lee WH; Lee CG; An J; Kim ES; Kim SH; Lee SK; Lee CH; Dhanasekaran DN; Moon A; Hwang S; Lee SJ; Park JW; Kim KM; Kim SG
Oncogene; 2015 May; 34(22):2910-21. PubMed ID: 25065598
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
Xu Y; Zhao S; Cui M; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
Yang XW; Shen GZ; Cao LQ; Jiang XF; Peng HP; Shen G; Chen D; Xue P
BMC Cancer; 2014 Dec; 14():909. PubMed ID: 25472505
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.
Kumar RN; Ha JH; Radhakrishnan R; Dhanasekaran DN
Mol Cell Biol; 2006 Jan; 26(1):50-62. PubMed ID: 16354679
[TBL] [Abstract][Full Text] [Related]
7. MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1.
Pei H; Jin Z; Chen S; Sun X; Yu J; Guo W
Mol Cell Biochem; 2015 Feb; 400(1-2):245-52. PubMed ID: 25416447
[TBL] [Abstract][Full Text] [Related]
8. HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1.
Xu H; Li G; Yue Z; Li C
Mol Med Rep; 2016 Jun; 13(6):5223-9. PubMed ID: 27108614
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma.
Li Y; Xu D; Bao C; Zhang Y; Chen D; Zhao F; Ding J; Liang L; Wang Q; Liu L; Li J; Yao M; Huang S; He X
Oncotarget; 2015 Feb; 6(4):2421-33. PubMed ID: 25537516
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
Qin Y; Li L; Wang F; Zhou X; Liu Y; Yin Y; Qi X
Cell Physiol Biochem; 2018; 48(4):1628-1637. PubMed ID: 30071508
[TBL] [Abstract][Full Text] [Related]
11. [MiR-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1].
Yue Z; Shen JJ; Huang QT; Qin YF; Li XN; Liu GB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):675-80. PubMed ID: 27222184
[TBL] [Abstract][Full Text] [Related]
12. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
[TBL] [Abstract][Full Text] [Related]
13. LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p.
Wang S; Xu M; Sun Z; Yu X; Deng Y; Chang H
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G116-G126. PubMed ID: 31021172
[TBL] [Abstract][Full Text] [Related]
14. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.
Xu D; He X; Chang Y; Xu C; Jiang X; Sun S; Lin J
Oncol Rep; 2013 Feb; 29(2):653-61. PubMed ID: 23151657
[TBL] [Abstract][Full Text] [Related]
18. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
[TBL] [Abstract][Full Text] [Related]
19. Gα
Kim KM; Han CY; Kim JY; Cho SS; Kim YS; Koo JH; Lee JM; Lim SC; Kang KW; Kim JS; Hwang SJ; Ki SH; Kim SG
J Hepatol; 2018 Mar; 68(3):493-504. PubMed ID: 29080810
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
Leung WK; He M; Chan AW; Law PT; Wong N
Cancer Lett; 2015 Jun; 362(1):97-105. PubMed ID: 25813403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
